HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth Lupu Selected Research

Ruth Lupu Research Topics

Disease

60Neoplasms (Cancer)
12/2023 - 08/2002
54Breast Neoplasms (Breast Cancer)
12/2022 - 01/2002
11Neoplasm Metastasis (Metastasis)
01/2022 - 08/2002
6Carcinogenesis
01/2017 - 11/2002
5Carcinoma (Carcinomatosis)
01/2017 - 11/2002
4Adenocarcinoma
11/2012 - 06/2004
3Hypoxia (Hypoxemia)
07/2006 - 01/2005
2Disease Progression
06/2017 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
07/2009 - 11/2005
2Endometrial Neoplasms (Endometrial Cancer)
09/2006 - 06/2004
2Hypersensitivity (Allergy)
05/2005 - 01/2005
2Obesity
03/2005 - 07/2004

Drug/Important Bio-Agent (IBA)

37Fatty Acid Synthases (Fatty Acid Synthase)IBA
12/2023 - 03/2004
21EnzymesIBA
10/2021 - 03/2004
19Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 03/2004
16Neuregulin-1 (Neuregulin 1)IBA
01/2022 - 08/2002
14histidine-rich proteinsIBA
01/2022 - 08/2002
14Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2002
9Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 01/2003
9Estrogen ReceptorsIBA
03/2021 - 01/2002
8Estrogens (Estrogen)FDA Link
03/2021 - 01/2002
7LigandsIBA
01/2022 - 08/2006
7Hormones (Hormone)IBA
01/2022 - 06/2005
6Trastuzumab (Herceptin)FDA Link
07/2009 - 06/2004
6Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2006 - 03/2004
5IntegrinsIBA
11/2022 - 01/2005
5TamoxifenFDA LinkGeneric
03/2021 - 05/2004
5Paclitaxel (Taxol)FDA LinkGeneric
06/2017 - 01/2005
5Messenger RNA (mRNA)IBA
07/2012 - 01/2002
4LipidsIBA
01/2022 - 01/2005
4Phenobarbital (Luminal)FDA Link
01/2022 - 09/2013
4Transcription Factors (Transcription Factor)IBA
01/2017 - 03/2004
4Antineoplastic Agents (Antineoplastics)IBA
12/2006 - 03/2004
4Malonyl Coenzyme A (Malonyl CoA)IBA
12/2006 - 06/2004
4CeruleninIBA
12/2006 - 03/2004
4Mitogen-Activated Protein KinasesIBA
10/2006 - 06/2004
3Estradiol (Delestrogen)FDA LinkGeneric
03/2021 - 06/2004
3Fulvestrant (Faslodex)FDA Link
10/2020 - 05/2004
3Olive OilIBA
01/2018 - 10/2006
3Oncogene Proteins (Oncogene Protein)IBA
07/2017 - 06/2004
3Phosphotransferases (Kinase)IBA
01/2017 - 08/2006
3DNA (Deoxyribonucleic Acid)IBA
11/2015 - 01/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 11/2002
3Integrin beta3 (GPIIIa)IBA
11/2007 - 05/2005
3Oleic Acid (Oleate)IBA
12/2006 - 10/2006
3MycotoxinsIBA
12/2006 - 06/2004
3Monounsaturated Fatty AcidsIBA
12/2006 - 10/2006
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2006 - 06/2004
3gamma-Linolenic AcidIBA
01/2005 - 05/2004
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2014
2Cadherins (E-Cadherin)IBA
01/2022 - 11/2012
2NADP (NADPH)IBA
10/2021 - 12/2006
2Progesterone Receptors (Progesterone Receptor)IBA
12/2020 - 06/2005
2CytokinesIBA
10/2020 - 04/2005
2Indicators and Reagents (Reagents)IBA
07/2017 - 06/2015
2Monoclonal AntibodiesIBA
05/2017 - 06/2015
2PolyphenolsIBA
01/2017 - 12/2006
2TeaIBA
01/2017 - 12/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2015 - 01/2005
2Plasminogen Activators (Plasminogen Activator)IBA
11/2012 - 08/2002
2Zoledronic Acid (Zometa)FDA Link
05/2011 - 11/2009
2Complementary DNA (cDNA)IBA
11/2009 - 05/2005
2Peptide Hydrolases (Proteases)FDA Link
09/2008 - 08/2002
2Integrin alpha ChainsIBA
11/2007 - 05/2005
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2007 - 08/2002
2Detergents (Detergent)IBA
12/2006 - 01/2005
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2006 - 01/2005
2AntigensIBA
12/2006 - 05/2005
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2006 - 01/2005
2Acetyl Coenzyme A (Acetyl-CoA)IBA
12/2006 - 01/2005
2Cytostatic AgentsIBA
12/2006 - 03/2004
2Orlistat (Xenical)FDA Link
12/2006 - 03/2005
2alpha-Linolenic Acid (Linolenic Acid)IBA
11/2006 - 03/2004
2Docosahexaenoic AcidsIBA
11/2006 - 03/2004
2SteroidsIBA
06/2005 - 06/2004
2OligonucleotidesIBA
05/2005 - 01/2005
2Double-Stranded RNA (RNA, Double Stranded)IBA
05/2005 - 01/2005
2Taxoids (Taxanes)IBA
05/2005 - 03/2004
2Epidermal Growth Factor (EGF)IBA
03/2005 - 01/2005
2U 0126 (UO 126)IBA
01/2005 - 06/2004
2Growth Factor ReceptorsIBA
01/2005 - 01/2005
2Drug CombinationsIBA
08/2004 - 06/2004
2Docetaxel (Taxotere)FDA Link
06/2004 - 03/2004
2Arachidonic Acid (Vitamin F)IBA
06/2004 - 03/2004
2Linoleic Acid (Linoleate)IBA
06/2004 - 03/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2003 - 11/2002
1NucleolinIBA
01/2022
1PalmitatesIBA
10/2021
1venetoclaxIBA
10/2021
1navitoclaxIBA
10/2021
1S63845IBA
10/2021
1ProteomeIBA
03/2021
1AgarIBA
03/2021
1Protein Isoforms (Isoforms)IBA
12/2020
1ProlactinIBA
12/2020
1Interleukin-8 (Interleukin 8)IBA
10/2020

Therapy/Procedure

16Therapeutics
12/2023 - 01/2003
7Drug Therapy (Chemotherapy)
05/2011 - 05/2003
3Mediterranean Diet
12/2006 - 10/2006
1Oral Administration
10/2021